Incidence and Predictors of Hyperkalemia in Patients With Heart Failure

This publication has 17 references indexed in Scilit:

• Quantification of the risk and predictors of hyperkalemia in patients with left ventricular dysfunction
  American Heart Journal, 2006
• Clinical factors associated with hyperkalemia in patients with congestive heart failure1
  Journal of Clinical Pharmacy and Therapeutics, 2005
• Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial
  The Lancet, 2003
• Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial
  The Lancet, 2003
• Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial
  The Lancet, 2003
• Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme
  The Lancet, 2003
• Renal Considerations in Angiotensin Converting Enzyme Inhibitor Therapy
  Circulation, 2001
• The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
  New England Journal of Medicine, 1999
• A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation
  Annals of Internal Medicine, 1999
• Hyperkalemia in Outpatients Using Angiotensin-Converting Enzyme Inhibitors
  Archives of internal medicine (1960), 1998